Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-24,379
Closed -$3.13M 999
2025
Q2
$3.13M Buy
24,379
+11,380
+88% +$1.11M 0.01% 665
2025
Q1
$939K Sell
12,999
-4,598
-26% -$489K ﹤0.01% 854
2024
Q4
$2M Sell
17,597
-40,406
-70% -$4.8M 0.01% 756
2024
Q3
$5.77M Buy
58,003
+14,422
+33% +$1.2M 0.02% 506
2024
Q2
$3.77M Sell
43,581
-17,837
-29% -$1.62M 0.01% 602
2024
Q1
$5.02M Buy
+61,418
New +$3.86M 0.02% 556
2023
Q4
Sell
-13,100
Closed -$487K 1139
2023
Q3
$487K Sell
13,100
-3,900
-23% -$129K ﹤0.01% 937
2023
Q2
$421K Buy
+17,000
New +$292K ﹤0.01% 963
2022
Q1
Sell
-23,600
Closed -$589K 1246
2021
Q4
$589K Sell
23,600
-98,400
-81% -$2.46M ﹤0.01% 1006
2021
Q3
$2.94M Buy
+122,000
New +$3.24M 0.01% 782

Other funds holding VRT

Axa's VRT Position: Q3 2025 in Review

Axa sold out of Vertiv (VRT) in Q3 2025, closing a stake of 24,379 shares — an estimated $3.13M sold.

Axa first reported a position in VRT in Q3 2021 and held it in 10 quarters. The position peaked at $5.77M in Q3 2024. 1,435 funds tracked by Wall St. Rank hold VRT as of Q3 2025.

  • Axa reported no remaining Vertiv position as of Q3 2025 after selling out during the quarter.
  • Axa sold 24,379 Vertiv shares in Q3 2025, an estimated $3.13M.
  • Axa first reported a position in Vertiv in Q3 2021 and held it in 10 quarters.
  • Axa's Vertiv position peaked at $5.77M in Q3 2024.
  • 1,435 funds tracked by Wall St. Rank held Vertiv as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.